4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-22-042262
Chief Executive Officer gave up 5,219 shares (to pay taxes)
- Chief Executive Officer acquired 1,504 shares (other)
- Chief Executive Officer acquired 19,768 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Quart Barry D Chief Executive Officer | 2022-04-29 | Other acquisition | +1,504 | $3.84 | $5,778 | 132,688 | D |
| Quart Barry D Chief Executive Officer | 2022-07-13 | Option exercise | +3,646 | 136,334 | D | ||
| Quart Barry D Chief Executive Officer | 2022-07-13 | Option exercise | +16,122 | 152,456 | D | ||
| Quart Barry D Chief Executive Officer | 2022-07-13 | Shares withheld for taxes | −5,219 | $3.01 | $15,709 | 147,237 | D |
| Derivatives | |||||||
| Quart Barry D Chief Executive Officer | 2022-07-13 | Option exercise · Restricted Stock Units | −3,646 | 32,812 | D | ||
| Quart Barry D Chief Executive Officer | 2022-07-13 | Option exercise · Restricted Stock Units | −16,122 | 147,051 | D | ||
Loading xslF345X03/doc4.xml…